CVRxvsUnitedHealth

CVRX and UNH stock compared: price, dividend, valuation and results, from SEC filings.

CVRX

CVRx, Inc.

$0.53

Value $15M

-1.15%
CVRX's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

CVRx (CVRX) has a market value of $15M and UnitedHealth (UNH) $300B. Over the last year, with dividends, CVRX moved -93.5% and UNH +12.1%. Dividend yield: CVRX none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CVRX$15M

    UNH$300B

    UNH is 19,761 times CVRX

  • Revenue, 12 months

    CVRX$60M

    UNH$450B

    UNH is 7,453 times CVRX

  • Net income, 12 months

    CVRX-$53M

    UNH$15.9B

  • Operating margin

    CVRX-81.9%

    UNH5.3%

    87.2 points apart

  • ROIC

    CVRX-45.9%

    UNH11.3%

    57.2 points apart

  • P/E

    CVRX–

    UNH18.9

  • Dividend yield

    CVRX0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    CVRX-96.0%

    UNH-14.7%

    81.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CVRX-96.0%

UNH-14.7%

010020020222023202420252026
Returns by period
PeriodCVRXWith dividendsUNHWith dividends
1 year since November 17, 2025-93.5%Price -93.5%+12.1%Price +9.2%
3 years since November 17, 2023-96.6%-67.6% a yearPrice -96.6%-30.5%-11.4% a yearPrice -34.8%
5 years since November 17, 2021-96.0%-47.4% a yearPrice -96.0%-14.7%-3.1% a yearPrice -22.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CVRXCVRxUNHUnitedHealth

Valuation

CVRXUNH
Valuation
Price$0.53$330.48
Market value$15M$300B
Enterprise value (EV)–$346B
P/E–18.9
P/E, 5-year median–25.0
P/B1.12.9
EV/EBIT–14.5
Free cash flow yield–7.6%

Results and growth

CVRXUNH
Results and growth
Revenue, 12 months$60M$450B
Net income, 12 months-$53M$15.9B
Free cash flow, 12 months-$42M$22.8B
Earnings per share, 12 months-$2.00$17.52
Revenue growth, year on year10.5%11.8%
Revenue growth a year, past+56.4%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

CVRXUNH
Margins and returns on capital
Gross margin86.9%88.3%
Operating margin-81.9%5.3%
Net margin-88.3%3.5%
ROIC-45.9%11.3%
ROE-177.2%15.5%

Balance sheet

CVRXUNH
Balance sheet
Cash$59M$28.5B
Total debt–$74.3B
Net debt / EBITDA–1.6
Interest cover-8.0×6.2×

Dividends and buybacks

CVRXUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CVRX or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, CVRx or UnitedHealth?

By market value, UnitedHealth ($300B) is about 19,761.2 times CVRx ($15M), at today's prices.

How did CVRX and UNH stock do over the last 5 years?

Since November 17, 2021, CVRX's price moved -96.0% and UNH's -22.1%. With dividends: CVRX -96.0% (-47.4% a year), UNH -14.7% (-3.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, CVRX or UNH?

The dividend yield at today's price is none for CVRx and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, CVRx or UnitedHealth?

Over the last twelve months, the net margin was -88.3% for CVRx and 3.5% for UnitedHealth, and the operating margin -81.9% and 5.3%. Revenue was $60M and $450B.

Which is the better investment, CVRx or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.